CLINICAL TRIALS PROFILE FOR PRIMATENE MIST
✉ Email this page to a colleague
All Clinical Trials for PRIMATENE MIST
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01357642 ↗ | Epinephrine Inhalation Aerosol USP: For Evaluation Of Efficacy And Safety In Asthma Patients | Completed | Amphastar Pharmaceuticals, Inc. | Phase 3 | 2011-07-01 | This clinical study evaluates the 12-week efficacy and safety of Epinephrine HFA Inhalation Aerosol HFA the proposed HFA formulation of metered dose inhaler (MDI) of Epinephrine, in comparison to a Placebo-HFA control MDI and the currently marketed Primatene® Mist (epinephrine CFC inhaler), in adolescent and adult subjects with asthma. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PRIMATENE MIST
Condition Name
Clinical Trial Locations for PRIMATENE MIST
Trials by Country
Clinical Trial Progress for PRIMATENE MIST
Clinical Trial Phase
Clinical Trial Sponsors for PRIMATENE MIST
Sponsor Name